In IBD model mice, activating the G-protein-coupled receptor 109A (GPR109A) receptor may have protective effects by suppressing the NF-κB signaling pathway and preserving the intestinal barrier [22]. The gene discussed is HCAR2; the disease is inflammatory bowel disease.